Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-06-11 DUGAN RICHARD W Director Grant or award +5,000 45,641
2020-06-11 DUGAN RICHARD W Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-06-11 Chrousos Phaedra Director Grant or award +5,000 10,000
2020-06-11 Chrousos Phaedra Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-05-29 Watkins Thomas Director Option exercise +15,000 $7.38 $111K 45,000
2020-05-29 Watkins Thomas Director Sale −9,677 $11.50 $111K 35,323
2020-05-29 Watkins Thomas Director Option exercise · Nonstatutory Stock Option (Right to Buy) −15,000 0
2020-05-28 DUGAN RICHARD W Director Option exercise +15,000 $7.38 $111K 50,770
2020-05-28 DUGAN RICHARD W Director Sale −10,129 $11.04 $112K 40,641
2020-05-28 DUGAN RICHARD W Director Option exercise · Nonstatutory Stock Option (Right to Buy) −15,000 0
2020-03-03 Williams Timothy SVP & General Counsel Sale −1,237 $10.51 $13K 83,040
2020-03-03 Polymeropoulos Mihael Hristos President and CEO Sale −5,152 $10.98 $57K 1,278,999
2020-03-03 Kelly James Patrick EVP & Chief Financial Officer Sale −5,889 $10.76 $63K 186,869
2020-03-03 Birznieks Gunther SVP, Business Development Sale −5,535 $10.66 $59K 159,473
2020-03-02 Williams Timothy SVP & General Counsel Sale −3,148 $10.30 $32K 84,277
2020-03-02 Reverberi Gian Piero SVP & Chief Commercial Officer Sale −1,450 $10.18 $15K 165,384
2020-03-02 Polymeropoulos Mihael Hristos President and CEO Sale −10,428 $10.57 $110K 1,284,151
2020-03-02 Kelly James Patrick EVP & Chief Financial Officer Sale −12,968 $10.19 $132K 192,758
2020-03-02 Birznieks Gunther SVP, Business Development Sale −12,223 $10.04 $123K 165,008
2020-02-26 Williams Timothy SVP & General Counsel Grant or award +30,000 87,425

Page 14 of 20 · 387 trades